ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles

Pancreatic cancer is an aggressive malignancy that often goes undiagnosed in the early stages. Non-invasive, early, and accurate diagnosis is therefore undoubtedly the “holy grail” of pancreatic cancer research. However, despite extensive research efforts, there is no definitive biomarker for this c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hye-Su, Jung, Sang Baek, Park, Sungho, Dua, Pooja, Lee, Dong ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819892/
https://www.ncbi.nlm.nih.gov/pubmed/31687420
http://dx.doi.org/10.1016/j.omtm.2019.08.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819892/
https://www.ncbi.nlm.nih.gov/pubmed/31687420
http://dx.doi.org/10.1016/j.omtm.2019.08.016

Ejemplares similares